High Intensity Focused Ultrasound Hifu Therapy Market Scope And Analysis

Report Code : TIPHE100001384
Category : Life Sciences

No. of Pages : 150

Buy Now

High Intensity Focused Ultrasound Therapy Market Analysis, Size, and Growth (2024-2031)

Buy Now

High Intensity Focused Ultrasound Therapy Market Report Scope

Report Attribute	Details
Market size in 2023	US$ 525.11 Million
Market Size by 2031	US$ 924.07 Million
Global CAGR (2023 - 2031)	7.3%
Historical Data	2021-2022
Forecast period	2024-2031
Segments Covered	By Modality Therapeutic Ultrasound Hemostasis By Method Non-Invasive Minimal-Invasive By Application Uterine Fibroids Prostate Cancer By End User Hospitals Research Centers Diagnostic Centers
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Koninklijke Philips N V Image Guided Therapy IGT EDAP TMS Sonacare Medical Chongqing Haifu Medical Technology Co Ltd Shanghai A S Science Technology Development Co Ltd Mianyang Sonic Electronic Insightec Ltd Alpinion Medical Systems Co Ltd FUS Instruments

High Intensity Focused Ultrasound Therapy Market News and Recent Developments

The high intensity focused ultrasound therapy market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the high intensity focused ultrasound therapy market are listed below:

SONIRE Therapeutics Inc. announced that NHK WOLRD’s “Medical Frontiers” would focus on HIFU therapy for pancreatic cancer, and the next-generation HIFU (High-Intensity Focused Ultrasound) therapy device, which has been developed by SONIRE, will be introduced in the program. (Source: SONIRE Therapeutics Inc., News, December 2023)
Theraclion, an innovative company developing a scalable robotic platform for non-invasive ultrasound therapy, announced that it launched the first treatments for its FDA-approved pivotal study on the treatment of varicose veins using SONOVEIN in the US. (Theraclion, Press Release, October 2023)
Theraclion, announced a phase-2 collaboration with the University of Virginia Cancer Center. This extends the investigation of combining HIFU with immunotherapy from late-stage to that of early-stage breast cancer. If successful, such a protocol could open a new way for treatment. (Source: Theraclion, Press Release, June 2021)

High Intensity Focused Ultrasound Therapy Market Report Coverage and Deliverables

The “High Intensity Focused Ultrasound Therapy Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

High intensity focused ultrasound therapy market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
High intensity focused ultrasound therapy market trends as well as market dynamics such as drivers, restraints, and key opportunities
Detailed PEST and SWOT analysis
High intensity focused ultrasound therapy market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the high intensity focused ultrasound therapy market
Detailed company profiles